Cellular and molecular responses of Saudi chronic myeloid leukaemia patients to imatinib (STI-571): ten year experience.

Alenzi, Faris Q; Al-Amri, Ali M; Alanazi, Fahad G B; Tamimi, Waleed; Alanazi, Ayad; Alenezy, Awwad K; Al-Swailmi, Farhan

Alenzi, Faris Q; Al-Amri, Ali M; Alanazi, Fahad G B; Tamimi, Waleed; Alanazi, Ayad; Alenezy, Awwad K; Al-Swailmi, Farhan.

Affiliation

Alenzi FQ; College of Applied Medical Sciences, Salman bin Abdulaziz University, Al-Kharj, Saudi Arabia. fqalenzi@ksu.edu.sa
Al-Amri AM; Internal Medicine Department, College of Medicine, University of Dammam, Saudi Arabia.
Alanazi FG; Pharmacy Department, MoH, Riyadh, Saudi Arabia.
Tamimi W; Biochemistry Department, KAMC, Riyadh, Saudi Arabia.
Alanazi A; Internal Medicine Department, College of Medicine, University of Dammam, Saudi Arabia.
Alenezy AK; Military Hospital, Riyadh, Saudi Arabia.
Al-Swailmi F; Medical College, Northern Borders University, Arar,

J Ayub Med Coll Abbottabad ; 24(2): 122-8, 2012.

Article in En | MEDLINE | ID: mdl-24397072

Subject(s)

Antineoplastic Agents/therapeutic use; Benzamides/therapeutic use; Leukemia, Myeloid, Chronic-Phase/drug therapy; Piperazines/therapeutic use; Pyrimidines/therapeutic use; Adolescent; Adult; Aged; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Saudi Arabia/epidemiology; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Leukemia, Myeloid, Chronic-Phase / Antineoplastic Agents Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Ayub Med Coll Abbottabad Journal subject: MEDICINA Year: 2012 Type: Article Affiliation country: Saudi Arabia

Search on Google

Add to My VHL

XML

PubMed Links